The Company operates in more than 100 markets worldwide, either directly or indirectly, through subsidiaries, joint ventures, licenses and distribution partnership agreements. With an on-going research covering all key modalities, Bracco Imaging has a strong presence in key geographies: North America, Europe and Japan operating through the Joint Venture Bracco-Eisai Co. Ltd. The Company also operates in Brazil, South Korea, and China through the Joint Venture Bracco Sine Pharmaceutical Corp. Ltd. Operational investments have been made in order to achieve top quality and compliances with a sustainable eco-friendly production. Manufacturing activities are located in Italy, Switzerland, Japan, China, and Germany. Bracco Imaging is an innovative Research and Development (R&D) player with an efficient process oriented approach and a track record of innovation in the diagnostic imaging industry. R&D activities are managed in the three Research Centres located in Italy, Switzerland, and USA.
To learn more about Bracco Imaging, visit www.braccoimaging.com.
About PHS Technologies Group LLC
PHS Technologies Group, LLC is a division of PACSHealth, LLC, a medical software development company based in Scottsdale, AZ, that develops software systems for medical imaging technology. PHS Technologies Group is committed to helping the medical community reduce patient exposure to ionizing radiation through advanced solutions that enable hospitals to manage patient radiation exposure and comply with regulatory requirements and industry guidelines while increasing efficiency and reducing cost.
For more information about DoseMonitor, please visit www.dosemonitor.com or call or email Mike Battin (877) 877-1457 x802; mike.battin@pacshealth.com.
SOURCE Bracco Imaging S.p.A.
Back to HCB News
